Skip to main content
SpringerLink
Log in

Monoclonal antibody targeting of anti-cancer agents

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Armitage NC, Perkins AC, Pimm MV, Farrands PA, Baldwin RW, Hardcastle JD (1984) The localisation of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours. Br J Surg 71: 407

    Google Scholar 

  2. Armitage NC, Perkins AC, Pimm MV, Wastie ML, Baldwin RW, Hardcastle JD (1985) Imaging of primary and metastatic colorectal cancer using an 111In-labelled antitumour monoclonal antibody (791T/36) Nucl Med Comm 6: 623

    Google Scholar 

  3. Baldwin RW (1983) Monoclonal antibodies for drug-targeting in cancer therapy. Pharmacy Int 4: 137

    Google Scholar 

  4. Baldwin RW (1985) Design and development of drug-monoclonal antibody 791T/36 for cancer therapy. In: Foon K, Morgan AC (eds) Monoclonal antibody therapy of human cancer. Martinus Nijhoff Publishing, pp 23–56

  5. Baldwin RW, Byers VS (eds) (1985) Monoclonal antibodies for cancer detection and therapy. Academic Press, London

    Google Scholar 

  6. Baldwin RW, Durrant L, Embleton MJ, Garnett M, Pimm MV, Robins RA, Hardcastle JD, Armitage NC, Ballantyne K (1985) Design and therapeutic evaluation of monoclonal antibody 791T/36-methotrexate conjugates. UCLA Symposium—Monoclonal antibodies and cancer therapy. 27: 215

    Google Scholar 

  7. Baldwin RW, Embleton MJ, Gallego J, Garnett M, Pimm MV, Price MR (1985) Monoclonal antibody drug conjugates for cancer therapy. In: Roth J (ed) Monoclonal antibodies for the diagnosis and therapy of cancer. Futura. (in press)

  8. Bradwell AR, Fairweather DS, Dykes PW (1985) Developments in antibody imaging. In: Baldwin RW, Byers VS (eds) Monoclonal antibodies for cancer detection and therapy. Academic Press, London pp 65–87

    Google Scholar 

  9. Buchegger F, Haskell CM, Schreyer M, Scazziga BR, Randin S, Carrel S, Mach J-P (1983) Radiolabelled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J Exp Med 158: 413

    Google Scholar 

  10. Casellas P, Brown JP, Gros O, Gros P, Hellstrom I, Jansen FK, Poncelet P, Roncucci R, Vidal H, Hellstrom KE (1982) Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97. Int J Cancer 30: 437

    Google Scholar 

  11. Casellas P, Bourrie BJP, Gros P, Jansen FK (1984) Kinetics of cytotoxicity induced by immunotoxins. J Biol Chem 259: 9359

    Google Scholar 

  12. Chatal JF, Douillard JY, Saccavini JC, Kremer M, Curtet C, Maurel C, Aubry J, Le Mevel B (1985) Clinical prospective study with radio-iodinated monoclonal antibodies directed against colorectal cancer. In: Baldwin RW, Byers VS (eds) Monoclonal antibodies for cancer detection and therapy. Academic Press, pp 159–180

  13. Embleton MJ, Byers VS, Garnett MC, Scannon PJ, Baldwin RW (1985) In vitro comparison between monoclonal antibody-targeted drug and toxin conjugates. Br J Cancer 52: 432

    Google Scholar 

  14. Gallego J, Price MR, Baldwin RW (1984) Preparation of four daunomycin-monoclonal antibody 791T/36 conjugates with anti-tumour activity. Int J Cancer 33: 737

    Google Scholar 

  15. Garnett MC, Embleton MJ, Jacobs E, Baldwin RW (1983) Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody-directed cytotoxicity in vitro. Int J Cancer 31: 661

    Google Scholar 

  16. Granowska M, Shepherd J, Britton KE, Ward B, Mather S, Taylor-Papadimitriou J, Epenetos AA, Carroll MJ, Nimmon CC, Hawkins LA, Slevein M, Flatman W, Horne T, Burchell J, Durbin H, Bodmer W (1984) Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findings. Nucl Med Comm 5: 485

    Google Scholar 

  17. Hwang KM, Foon KA, Cheung PH, Pearson JW, Oldham RK (1984) Selective antitumor effect on L10 hepatocarcinoma cells or a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen. Cancer Res 44: 4578

    Google Scholar 

  18. Jansen FK, Laurent G, Liance MC, Blythman HE, Berthe J, Canat X, Carayon P, Carriere D, Casellas P, Derocq JM, Dussossoy D, Fauser AA, Gorin NC, Gros O, Gros P, Laurent JC, Poncelet P, Remandet B, Richer G, Vidal H (1985) Efficiency and tolerance of the treatment with immuno-A-chain-toxins in human bone marrow transplantations. In: Baldwin RW, Byers VS (eds) Monoclonal antibodies for tumour detection and drug targeting. Academic Press, London, pp 224–249

    Google Scholar 

  19. Larson SM, Carrasquillo JA, Krohn KA, Brown JP, McGuffin RW, Ferens JM, Graham MM, Hill LD, Beaumier PL, Hellstrom KE, Hellstrom I (1983) Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. J Clin Invest 72: 2101

    Google Scholar 

  20. Mach J-P, Buchegger F, Grob JPh, von Fliedner V, Carrel S, Barrelet L, Bischof-Delaloye A, Delaloye B (1985) Improvement of colon carcinoma imaging: from polyclonal anti-CEA antibodies and static photoscanning to monoclonal Fab fragments and emission computerized tomography (ECT). In: Baldwin RW, Byers VS (eds) Monoclonal antibodies for cancer detection and therapy. Academic Press, London, pp 53–64

    Google Scholar 

  21. Myers C (1985) The use of immunotoxins to eliminate tumour cells from human leukaemic marrow autografts. In: Baldwin RW, Byers VS (eds) Monoclonal antibodies for tumour detection and drug targeting. Academic Press, London, pp 250–268

    Google Scholar 

  22. Myers CD, Thorpe PE, Ross WCJ, Cumber AJ, Katz FE, Tax W, Greaves MF (1984) An immunotoxin with therapeutic potential in T cell leukemia: WT1-Ricin A. Blood 63: 1178

    Google Scholar 

  23. Pimm MV, Baldwin RW (1984) Quantitative evaluation of the localization of a monoclonal antibody (791T/36) in human osteogenic sarcoma xenografts. Eur J Cancer Clin Oncol 20: 515

    Google Scholar 

  24. Pimm MV, Embleton MJ, Perkins AC, Price MR, Robins RA, Robinson GR, Baldwin RW (1982) In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts. Int J Cancer 30: 75

    Google Scholar 

  25. Rainsbury RM, Ott RJ, Westwood JH, Kalirai TS Coombes RC, McCready VR, Neville AM, Gazet J-C (1983) Localisation of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Lancet II: 934

    Google Scholar 

  26. Rowland GF, Simmonds RG, Corvalan JRF, Baldwin RW, Brown JP, Embleton MJ, Ford CHJ, Hellstrom KE, Hellstrom I, Kemshead JT, Newman CE, Woodhouse CS (1983) Monoclonal antibodies for targeted therapy with vindesine. In: Peeters H (ed) Protides of the biological fluids, vol 30. Pergamon Press, Oxford, p 375

    Google Scholar 

  27. Rowland GF, Axton CA, Baldwin RW, Brown JP, Corvalan JRF, Embleton MJ, Gore VA, Hellstrom I, Hellstrom KE, Jacobs E, Marsden CH, Pimm MV, Simmonds RG, Smith W (1985) Antitumor properties of vindesine-monoclonal antibody conjugates. Cancer Immunol Immunother pp 19: 1

  28. Symonds EM, Perkins AC, Pimm MV, Baldwin RW, Hardy JG, Williams DA (1985) Clinical implications for immunoscintigraphy in patients with ovarian malignancy, a preliminary study using monoclonal antibody 7917/36 Br J Obstet Gynaecol 92: 270

    Google Scholar 

  29. Tax WJM, Tidiman N, Janossy G, Trejdosiewicz L, Willems R, Leeuwenberg J, De Witte TJM, Capel PJA, Koene RAP (1984) Monoclonal antibody (WT 1) directed against a T cell surface glycoprotein: characteristics and immunosuppressive activity. Clin Exp Immunol 55: 427

    Google Scholar 

  30. Thompson CH, Lichtenstein M, Stacker SA, Leyden MJ, Salehi N, Andrews JT, McKenzie JFC (1984) Immunoscintigraphy for detection of lymph node metastases from breast cancer. Lancet II: 1245

    Google Scholar 

  31. Uhr JW (1984) Immunotoxins: harnessing nature's poisons. J Immunol 133/6: i

    Google Scholar 

  32. Vitetta ES, Cushley W, Uhr JW (1983) Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells. Proc Natl Acad Sci USA 80: 6332

    Google Scholar 

  33. Vitetta ES, Krolick KA, Miyama-Inaba WC, Cushley W, Uhr JW (1983) Immunotoxins: a new approach to cancer therapy. Science 219: 644

    Google Scholar 

  34. Vitetta ES, Fulton RJ, Uhr JW (1984) The cytotoxicity of cell-reactive immunotoxin containing ricin A chain is potentiated with an anti-immunotoxin containing ricin B chain. J Exp Med 160: 341

    Google Scholar 

  35. Williams MR, Perkins AC, Campbell FC, Pimm MV, Hardy JG, Wastie ML, Blamey RW, Baldwin RW (1985) The use of monoclonal antibody 791T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breast. Clin Oncol 10: 375

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Research Campaign Laboratories, University of Nottingham, NG7 2RD, Nottingham, UK

    R. W. Baldwin

  2. XOMA Corporation, 2910 Seventh Street, 94710, Berkeley, CA, USA

    V. S. Byers

Authors
  1. R. W. Baldwin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. S. Byers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baldwin, R.W., Byers, V.S. Monoclonal antibody targeting of anti-cancer agents. Springer Semin Immunopathol 9, 39–50 (1986). https://doi.org/10.1007/BF00201904

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00201904

Keywords

Search

Navigation